Alcon Inc. (ALC) and Koninklijke Philips N.V. (PHG) operate in the healthcare sector, with ALC specializing in eye care solutions and PHG offering broader health technology products. This comparison is relevant for investors eyeing medical devices and diagnostics amid evolving market dynamics, including new product launches and sector-wide pressures. Traders focused on relative performance, valuation trade-offs, and momentum shifts in recent weeks will find insights into how these stocks position against each other in the current environment.
Alcon Inc. (ALC) is a global leader in eye care, providing surgical equipment, intraocular lenses, and vision care products like contact lenses. In recent market activity, the stock has traded around $74, within a 52-week range of $71.55 to $98.56, reflecting a year-to-date gain of about 6.58% despite weekly dips. Key developments include the April 30, 2026, Annual General Meeting approving a CHF 0.28 dividend (ex-date May 6) and collaborations like with PerZeption Inc. for vision research. Sentiment has been influenced by solid Q4 2025 results with revenue growth from new launches, though broader medtech tariff concerns have pressured shares recently.
Koninklijke Philips N.V. (PHG) focuses on health technology across diagnosis & treatment, connected care, and personal health segments. Shares recently closed near $26, with a market cap of $25 billion. Recent weeks have seen downward momentum, with a weekly decline of 4.77% and year-to-date around -3% to flat, amid mixed sector trends. Influences include strong Q4 2025 results showing revenue up 1.8% and profit surges in connected care, alongside upcoming Q1 earnings. Higher debt levels have tempered enthusiasm, but improving margins support positioning in a recovering health tech landscape.
Tickeron’s Trending AI Robots page curates 25 top performers from over 350 AI Trading Bots that analyze thousands of tickers across diverse strategies, timeframes from 5 minutes to 60 minutes, and styles like technical, fundamental, or volatility-based. These bots deliver real-time signals for copy trading, boasting impressive stats such as annualized returns of 93% to 163%, win rates of 56% to 75%, and profit factors up to 3.33. Examples include semiconductor-focused bots with 96.99% returns and small-cap trend traders at 93.40% annualized. While none currently target ALC or PHG directly, the platform's adaptable bots suit varying market conditions. Investors can explore these high-performing options to enhance their trading edge.
ALC’s specialized eye care model contrasts with PHG’s diversified health tech exposure, offering ALC focused growth drivers like IOL implants surpassing 175 million, versus PHG’s scale in connected care. Valuation-wise, PHG appears cheaper with lower forward PE and PEG ratio (0.36), though ALC wins on lower debt/equity and higher ROE potential. Recent momentum favors neither strongly, with both facing sector risks like tariffs, but ALC’s beta of 0.74 indicates less volatility. Market sentiment tilts toward PHG’s undervaluation amid profitability gains, balancing ALC’s stability trade-offs.
Tickeron’s AI currently leans toward PHG with a "Buy" long-term outlook over ALC’s "Hold," driven by superior valuation metrics, higher profit-vs-risk rating (100), and undervalued status despite elevated debt. Factors like trend consistency in connected care and lower forward multiples suggest probabilistic upside, while ALC offers stability via low beta and catalysts like earnings on May 5. Relative positioning favors PHG in the near term absent major shifts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALC’s FA Score shows that 0 FA rating(s) are green whilePHG’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALC’s TA Score shows that 3 TA indicator(s) are bullish while PHG’s TA Score has 6 bullish TA indicator(s).
ALC (@Pharmaceuticals: Other) experienced а +1.73% price change this week, while PHG (@Medical/Nursing Services) price change was -3.66% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.52%. For the same industry, the average monthly price growth was -4.78%, and the average quarterly price growth was +19.71%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.53%. For the same industry, the average monthly price growth was -5.85%, and the average quarterly price growth was -5.88%.
ALC is expected to report earnings on Aug 10, 2026.
PHG is expected to report earnings on Jul 28, 2026.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-1.53% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ALC | PHG | ALC / PHG | |
| Capitalization | 31.5B | 24.6B | 128% |
| EBITDA | 2.54B | 2.68B | 95% |
| Gain YTD | -19.249 | -3.201 | 601% |
| P/E Ratio | 38.11 | 21.54 | 177% |
| Revenue | 10.6B | 17.6B | 60% |
| Total Cash | 1.66B | N/A | - |
| Total Debt | 5.25B | N/A | - |
ALC | PHG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 51 | 4 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 39 Fair valued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 87 | 76 | |
PRICE GROWTH RATING 1..100 | 86 | 62 | |
P/E GROWTH RATING 1..100 | 50 | 99 | |
SEASONALITY SCORE 1..100 | 50 | 32 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PHG's Valuation (3) in the Electronic Production Equipment industry is somewhat better than the same rating for ALC (39) in the Hospital Or Nursing Management industry. This means that PHG’s stock grew somewhat faster than ALC’s over the last 12 months.
PHG's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as ALC (100) in the Hospital Or Nursing Management industry. This means that PHG’s stock grew similarly to ALC’s over the last 12 months.
PHG's SMR Rating (76) in the Electronic Production Equipment industry is in the same range as ALC (87) in the Hospital Or Nursing Management industry. This means that PHG’s stock grew similarly to ALC’s over the last 12 months.
PHG's Price Growth Rating (62) in the Electronic Production Equipment industry is in the same range as ALC (86) in the Hospital Or Nursing Management industry. This means that PHG’s stock grew similarly to ALC’s over the last 12 months.
ALC's P/E Growth Rating (50) in the Hospital Or Nursing Management industry is somewhat better than the same rating for PHG (99) in the Electronic Production Equipment industry. This means that ALC’s stock grew somewhat faster than PHG’s over the last 12 months.
| ALC | PHG | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 57% | 2 days ago 74% |
| Stochastic ODDS (%) | 2 days ago 63% | 2 days ago 52% |
| Momentum ODDS (%) | 2 days ago 51% | 2 days ago 57% |
| MACD ODDS (%) | 2 days ago 55% | 2 days ago 62% |
| TrendWeek ODDS (%) | 2 days ago 58% | 2 days ago 62% |
| TrendMonth ODDS (%) | 2 days ago 50% | 2 days ago 60% |
| Advances ODDS (%) | N/A | 11 days ago 62% |
| Declines ODDS (%) | 6 days ago 55% | 2 days ago 65% |
| BollingerBands ODDS (%) | 2 days ago 67% | 2 days ago 83% |
| Aroon ODDS (%) | 2 days ago 53% | 2 days ago 56% |
A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.
A.I.dvisor indicates that over the last year, PHG has been loosely correlated with RYLPF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PHG jumps, then RYLPF could also see price increases.
| Ticker / NAME | Correlation To PHG | 1D Price Change % | ||
|---|---|---|---|---|
| PHG | 100% | -1.06% | ||
| RYLPF - PHG | 56% Loosely correlated | N/A | ||
| GEHC - PHG | 52% Loosely correlated | -3.05% | ||
| ALC - PHG | 49% Loosely correlated | -0.56% | ||
| CNMD - PHG | 46% Loosely correlated | -2.34% | ||
| ENOV - PHG | 44% Loosely correlated | -7.01% | ||
More | ||||